The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
The proliferating role of insulin and insulin-like growth factors in cancer
Open accessAbstract
Epidemiological studies have reported an increased risk of cancer in those with type 2 diabetes (T2DM) and obesity, related in part to hyperinsulinemia, secondary to insulin resistance. Hyperinsulinemia leads to increased insulin-like growth factor-1 (IGF-I) expression. In fact, increased insulin, IGF-I and IGF-II levels are associated with tumor growth in vitro, in animal models and in epidemiological studies in humans. Herein, we discuss insulin, IGF-I and IGF-II, their interaction with the insulin receptor (IR) and IGF-I receptor (IGF-IR), and their signaling pathways and regulation as it pertains to tumor growth. We explain how these pathways have been deciphered by in vitro and in vivo studies and how they are being exploited in the development of targeted cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Karp, D. D., Paz-Ares, L. G., Novello, S., Haluska, P., Garland, L., Cardenal, F., Blakely, L. J., Eisenberg, P. D., Langer, C. J., Blumenschein, G., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9331 · Cited by 260
RetractedOverweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Self-citationBowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 1×
“In human epidemiological studies, metformin has been associated with a decreased risk of cancer development and a better response to chemotherapy in patients with breast cancer [70,71].”
BackgroundInduction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., & Semenza, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203781200 · Cited by 821
Stacey, S. N., Manolescu, A., Sulem, P., Rafnar, T., Gudmundsson, J., Gudjonsson, S. A., Masson, G., Jakobsdottir, M., Thorlacius, S., Helgason, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2064 · Cited by 786
Dunnwald, L. K., Rossing, M. A., & Li, C. I. (2007) · Breast Cancer Research · doi:10.1186/bcr1639 · Cited by 785
Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Li, J., Ho, G. Y. F., Xue, X., Anderson, G. L., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn415 · Cited by 563
Alimova, I. N., Liu, B., Fan, Z., Edgerton, S. M., Dillon, T., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7933 · Cited by 523
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes
Landman, G. W. D., Kleefstra, N., van Hateren, K. J. J., Groenier, K. H., Gans, R. O. B., & Bilo, H. J. G. (2010) · Diabetes Care · doi:10.2337/dc09-1380 · Cited by 502
Dunn, S. E., Kari, F. W., French, J. E., Leininger, J. R., Travlos, G. S., Wilson, R., & Barrett, J. C. (1997) · PubMed · Cited by 438
Ma, J., Li, H., Giovannucci, E., Mucci, L., Qiu, W., Nguyen, P. L., Gaziano, J. M., Pollak, M., & Stampfer, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70235-3 · Cited by 421
PTEN, more than the AKT pathway
Blanco-Aparicio, C., Renner, O., Leal, J. F. M., & Carnero, A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm052 · Cited by 403
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu, Y., Yakar, S., Zhao, L., Hennighausen, L. G., & LeRoith, D. (2002) · PubMed · Cited by 380
Self-citationFunctional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369
Self-citationModifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer
Clemmons, D. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2359 · Cited by 340
Lee, A. V. (1999) · Molecular Endocrinology · doi:10.1210/me.13.5.787 · Cited by 340
Elevated insulin receptor content in human breast cancer
Papa, V, Pezzino, V, Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G. B., Brand, R., Goldfine, I. D., & Vigneri, R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114868 · Cited by 338
A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men
Ma, J., Giovannucci, E., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J. M., & Stampfer, M. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh082 · Cited by 329
Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Jogie-Brahim, S., Feldman, D., & Oh, Y. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0028 · Cited by 323
Coordination and communication between the p53 and IGF-1–AKT–TOR signal transduction pathways
Levine, A. J., Feng, Z., Mak, T. W., You, H., & Jin, S. (2006) · Genes & Development · doi:10.1101/gad.1363206 · Cited by 321
Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice
Sakatani, T., Kaneda, A., Iacobuzio-Donahue, C. A., Carter, M. G., de Boom Witzel, S., Okano, H., Ko, M. S. H., Ohlsson, R., Longo, D. L., & Feinberg, A. P. (2005) · Science · doi:10.1126/science.1108080 · Cited by 321
Reiling, J. H., & Sabatini, D. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209889 · Cited by 311
Sciacca, L., Costantino, A., Pandini, G., Mineo, R., Frasca, F., Scalia, P., Sbraccia, P., Goldfine, I. D., Vigneri, R., & Belfiore, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202600 · Cited by 288
Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 282
Self-citationDiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltrán, L., Moats, S., Ramirez, A., Jorcano, J., & Conti, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3455 · Cited by 281
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Carboni, J. M., Wittman, M., Yang, Z., Lee, F., Greer, A., Hurlburt, W., Hillerman, S., Cao, C., Cantor, G. H., Dell-John, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0499 · Cited by 280
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Manson, J. E., Li, J., Harris, T. G., Rohan, T. E., Xue, X., Ho, G. Y. F., et al. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2686 · Cited by 267
Rinaldi, S., Cleveland, R., Norat, T., Biessy, C., Rohrmann, S., Linseisen, J., Boeing, H., Pischon, T., Panico, S., Agnoli, C., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.24927 · Cited by 244
Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
Jiang, B.-H., & Liu, L.-Z. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.03.001 · Cited by 243
Algire, C., Amrein, L., Zakikhani, M., Panasci, L., & Pollak, M. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0252 · Cited by 234
Jelinic, P., & Shaw, P. (2007) · The Journal of Pathology · doi:10.1002/path.2116 · Cited by 229
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Howard, B. V., Wylie-Rosett, J., Anderson, G. L., Ho, G. Y. F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2946 · Cited by 229
Insulin receptor expression by human prostate cancers
Cox, M. E., Gleave, M. E., Zakikhani, M., Bell, R. H., Piura, E., Vickers, E., Cunningham, M., Larsson, O., Fazli, L., & Pollak, M. (2009) · The Prostate · doi:10.1002/pros.20852 · Cited by 223
Butt, A. J., Firth, S. M., King, M. A., & Baxter, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908888199 · Cited by 214
Wu, Y., Cui, K. Y., Miyoshi, K., Hennighausen, L. G., Green, J. E., Setser, J., LeRoith, D., & Yakar, S. (2003) · PubMed · Cited by 201
Self-citationFan, Q.-W., Cheng, C. K., Nicolaides, T. P., Hackett, C. S., Knight, Z. A., Shokat, K. M., & Weiss, W. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2154 · Cited by 192
Jenab, M., Riboli, E., Cleveland, R. J., Norat, T., Rinaldi, S., Nieters, A., Biessy, C., Tjønneland, A., Olsen, A., Overvad, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22697 · Cited by 187
Polycystic Ovary Syndrome: A Syndrome of Ovarian Hypersensitivity to Insulin?
Baillargeon, J.-P., & Nestler, J. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1804 · Cited by 169
Rinaldi, S., Peeters, P. H. M., Berrino, F., Dossus, L., Biessy, C., Olsen, A., Tjonneland, A., Overvad, K., Clavel-Chapelon, F., Boutron-Ruault, M. C., et al. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01150 · Cited by 164
Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones
Yakar, S., Núñez, N. P., Pennisi, P. A., Brodt, P., Sun, H., Fallavollita, L., Zhao, H., Scavo, L. M., Novosyadlyy, R., Kurshan, N., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0311 · Cited by 155
Self-citationIGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells
Perks, C. M., Vernon, E. G., Rosendahl, A. H., Tonge, D. W., & Holly, J. M. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210397 · Cited by 143
Insulin injections promote the growth of aberrant crypt foci in the colon of rats
Corpet, D. E., Jacquinet, C., Peiffer, G., et al. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514543 · Cited by 139
Bonnette, S. G., & Hadsell, D. L. (2001) · Endocrinology · doi:10.1210/endo.142.11.8500 · Cited by 138
Ingermann, A. R., Yang, Y.-F., Han, J., Mikami, A., Garza, A., Mohanraj, L., Fan, L., Idowu, M. O., Ware, J. L., Kim, H.-S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.122226 · Cited by 137
Wang, Y. Z., & Wong, Y. C. (1998) · The Prostate · Cited by 123
Héron‐Milhavet, L., & LeRoith, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111142200 · Cited by 122
Self-citationInhibition of cancer cell proliferation and metastasis by insulin receptor downregulation
Zhang, H., Fagan, D. H., Zeng, X., Freeman, K. T., Sachdev, D., & Yee, D. (2010) · Oncogene · doi:10.1038/onc.2010.17 · Cited by 120
Heuson, J.-C., Legros, N., & Heimann, R. (1972) · PubMed · Cited by 120
Scotlandi, K., Avnet, S., Benini, S., Manara, M. C., Serra, M., Cerisano, V., Perdichizzi, S., Lollini, P., Giovanni, C. D., Landuzzi, L., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10537 · Cited by 110
Chen, W., Wang, S., Tian, T., Bai, J., Hu, Z., Xu, Y., Dong, J., Chen, F., Wang, X., & Shen, H. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.86 · Cited by 110
Cust, A. E., Allen, N. E., Rinaldi, S., Dossus, L., Friedenreich, C. M., Olsen, A., Tjønneland, A. M., Overvad, K., Clavel‐Chapelon, F., Boutron‐Ruault, M., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22578 · Cited by 102
Kaneda, A., Wang, C. J., Cheong, R., Timp, W., Onyango, P. O., Wen, B., Iacobuzio–Donahue, C. A., OHLSSON, R. I., Andraos, R., Pearson, M. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710359105 · Cited by 102
Verheus, M., Peeters, P. H. M., Rinaldi, S., Dossus, L., Biessy, C., Olsen, A., Tjønneland, A. M., Overvad, K., Jeppesen, M., Clavel‐Chapelon, F., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21861 · Cited by 102
Haluska, P., Carboni, J. M., TenEyck, C. J., Attar, R. M., Hou, X., Yu, C., Sagar, M., Wong, T. W., Gottardis, M. M., & Erlichman, C. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0493 · Cited by 102
The molecular and cellular biology of insulin-like growth factor II
Nielsen, F. C. (1992) · Progress in Growth Factor Research · doi:10.1016/0955-2235(92)90023-b · Cited by 99
Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression
Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2009) · Diabetes · doi:10.2337/db09-1291 · Cited by 93
Self-citationCanonici, A., Steelant, W. F. A., Rigot, V., Khomitch‐Baud, A., Boutaghou‐Cherid, H., Bruyneel, E. A., Roy, F. M. V., Garrouste, F. L., Pommier, G. J., & André, F. (2007) · International Journal of Cancer · doi:10.1002/ijc.23164 · Cited by 91
Silha, J. V., Sheppard, P. C., Mishra, S., Gui, Y., Schwartz, J., Dodd, J. G., & Murphy, L. J. (2006) · Endocrinology · doi:10.1210/en.2005-1270 · Cited by 90
Insulin-Like Growth Factor-I and Cancer Mortality in Older Men
Major, J. M., Laughlin, G. A., Kritz‐Silverstein, D. C., Wingard, D. L., & Barrett-Connor, E. L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1378 · Cited by 76
Eliassen, A. H., Tworoger, S. S., Mantzoros, C. S., Pollak, M., & Hankinson, S. E. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0693 · Cited by 75
Lee, C., Park, K. H., Adachi, Y., et al. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700524 · Cited by 72
Insulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland
Moorehead, R. A., Hojilla, C. V., de Belle, I., Wood, G. A., Fata, J. E., Adamson, E. D., Watson, K. L. M., Edwards, D. R., & Khokha, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306894200 · Cited by 70
Tran, T. T., Gupta, N., Goh, T. T., Naigamwalla, D. Z., Chia, M. C., Koohestani, N., Mehrotra, S., McKeown‐Eyssen, G., Giacca, A., & Bruce, W. R. (2003) · PubMed · Cited by 68
Insulin-like growth factor I stimulates motility in human neuroblastoma cells
Meyer, G. E., Shelden, E. A., Kim, B., & Feldman, E. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204927 · Cited by 65
Neuhausen, S. L., Brummel, S. S., Ding, Y. C., Singer, C. F., Pfeiler, G., Lynch, H. T., Nathanson, K. L., Rebbeck, T. R., Garber, J. E., Couch, F. J., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2414 · Cited by 55
Wang, Y., Lipari, P., Wang, X., Hailey, J., Liang, L., Ramos, R., Liu, M., Pachter, J. A., Bishop, W. R., & Wang, Y. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0555 · Cited by 42
Rensing, K. L., Bloemendaal, F. M., Weijers, E. M., Richel, D. J., Buller, H. R., Koolwijk, P., van der Loos, C. M., Twickler, T. B., & von der Thüsen, J. H. (2010) · Diabetologia · doi:10.1007/s00125-010-1687-y · Cited by 40
Fukuda, I., Hizuka, N., Itoh, E., Yasumoto, K., Ishikawa, Y., Murakami, Y., Sata, A., & Takano, K. (2002) · Endocrine Journal · doi:10.1507/endocrj.49.379 · Cited by 22
Cited by
Obesity as a Major Risk Factor for Cancer
De Pergola, G., & Silvestris, F. (2013) · Journal of Obesity · doi:10.1155/2013/291546 · Cited by 959
Cellular Metabolic Stress: Considering How Cells Respond to Nutrient Excess
Wellen, K. E., & Thompson, C. B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.004 · Cited by 486
The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun
Sundaresan, N. R., Vasudevan, P., Zhong, L., Kim, G., Samant, S., Parekh, V., Pillai, V. B., Ravindra, P. V., Gupta, M., Jeevanandam, V., et al. (2012) · Nature Medicine · doi:10.1038/nm.2961 · Cited by 476
Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Lega, I. C., & Lipscombe, L. L. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz014 · Cited by 364
The Link between the Metabolic Syndrome and Cancer
Braun, S., Bitton-Worms, K., & LeRoith, D. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1003 · Cited by 326
Self-citation
Metadata
- Authors
- Gallagher, E. J., & LeRoith, D.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 21
- Issue
- 10
- Pages
- 610-618
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W1993248218
- Cited by
- 380
- References
- 79
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.